API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
41
PharmaCompass offers a list of Methotrexate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methotrexate manufacturer or Methotrexate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methotrexate manufacturer or Methotrexate supplier.
PharmaCompass also assists you with knowing the Methotrexate API Price utilized in the formulation of products. Methotrexate API Price is not always fixed or binding as the Methotrexate Price is obtained through a variety of data sources. The Methotrexate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Methotrexate, Disodium Salt manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methotrexate, Disodium Salt, including repackagers and relabelers. The FDA regulates Methotrexate, Disodium Salt manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methotrexate, Disodium Salt API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Methotrexate, Disodium Salt manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Methotrexate, Disodium Salt supplier is an individual or a company that provides Methotrexate, Disodium Salt active pharmaceutical ingredient (API) or Methotrexate, Disodium Salt finished formulations upon request. The Methotrexate, Disodium Salt suppliers may include Methotrexate, Disodium Salt API manufacturers, exporters, distributors and traders.
click here to find a list of Methotrexate, Disodium Salt suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Methotrexate, Disodium Salt DMF (Drug Master File) is a document detailing the whole manufacturing process of Methotrexate, Disodium Salt active pharmaceutical ingredient (API) in detail. Different forms of Methotrexate, Disodium Salt DMFs exist exist since differing nations have different regulations, such as Methotrexate, Disodium Salt USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Methotrexate, Disodium Salt DMF submitted to regulatory agencies in the US is known as a USDMF. Methotrexate, Disodium Salt USDMF includes data on Methotrexate, Disodium Salt's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Methotrexate, Disodium Salt USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Methotrexate, Disodium Salt suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Methotrexate, Disodium Salt Drug Master File in Japan (Methotrexate, Disodium Salt JDMF) empowers Methotrexate, Disodium Salt API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Methotrexate, Disodium Salt JDMF during the approval evaluation for pharmaceutical products. At the time of Methotrexate, Disodium Salt JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Methotrexate, Disodium Salt suppliers with JDMF on PharmaCompass.
A Methotrexate, Disodium Salt CEP of the European Pharmacopoeia monograph is often referred to as a Methotrexate, Disodium Salt Certificate of Suitability (COS). The purpose of a Methotrexate, Disodium Salt CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Methotrexate, Disodium Salt EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Methotrexate, Disodium Salt to their clients by showing that a Methotrexate, Disodium Salt CEP has been issued for it. The manufacturer submits a Methotrexate, Disodium Salt CEP (COS) as part of the market authorization procedure, and it takes on the role of a Methotrexate, Disodium Salt CEP holder for the record. Additionally, the data presented in the Methotrexate, Disodium Salt CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Methotrexate, Disodium Salt DMF.
A Methotrexate, Disodium Salt CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Methotrexate, Disodium Salt CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Methotrexate, Disodium Salt suppliers with CEP (COS) on PharmaCompass.
A Methotrexate, Disodium Salt written confirmation (Methotrexate, Disodium Salt WC) is an official document issued by a regulatory agency to a Methotrexate, Disodium Salt manufacturer, verifying that the manufacturing facility of a Methotrexate, Disodium Salt active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Methotrexate, Disodium Salt APIs or Methotrexate, Disodium Salt finished pharmaceutical products to another nation, regulatory agencies frequently require a Methotrexate, Disodium Salt WC (written confirmation) as part of the regulatory process.
click here to find a list of Methotrexate, Disodium Salt suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Methotrexate, Disodium Salt as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Methotrexate, Disodium Salt API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Methotrexate, Disodium Salt as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Methotrexate, Disodium Salt and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Methotrexate, Disodium Salt NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Methotrexate, Disodium Salt suppliers with NDC on PharmaCompass.
Methotrexate, Disodium Salt Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Methotrexate, Disodium Salt GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Methotrexate, Disodium Salt GMP manufacturer or Methotrexate, Disodium Salt GMP API supplier for your needs.
A Methotrexate, Disodium Salt CoA (Certificate of Analysis) is a formal document that attests to Methotrexate, Disodium Salt's compliance with Methotrexate, Disodium Salt specifications and serves as a tool for batch-level quality control.
Methotrexate, Disodium Salt CoA mostly includes findings from lab analyses of a specific batch. For each Methotrexate, Disodium Salt CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Methotrexate, Disodium Salt may be tested according to a variety of international standards, such as European Pharmacopoeia (Methotrexate, Disodium Salt EP), Methotrexate, Disodium Salt JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Methotrexate, Disodium Salt USP).